欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
NL/H/0829/002
药品名称
Piperacilline-tazobactam TEVA
活性成分
piperacillin 4000.0 mg
tazobactam 500.0 mg
剂型
Powder for solution for injection
上市许可持有人
Pharmachemie B.V Netherlands
参考成员国 - 产品名称
Netherlands (NL)
互认成员国 - 产品名称
Germany (DE)
Piperacillin / Tazobactam -GRY 4g/ 0,5g Pulver z. Herst. einer Injektions- o.Inf.lösung
Slovenia (SI)
Lithuania (LT)
Estonia (EE)
许可日期
2010/03/08
最近更新日期
2024/06/04
药物ATC编码
J01CR05 piperacillin and beta-lactamase inhibitor
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final SPC
|
Common_Piperacillin_Tazobactam_NL_H_0829_001_002_SmPC_15_05_23
Date of last change:2023/09/13
Final PL
|
NL_H_0829_001_IA_017_common_spc_clean
Date of last change:2022/06/02
Final PL
|
NL_H_0829_001_IA_017_common_pl_clean
Date of last change:2022/06/02
Final Labelling
|
Final_Common_Label_clean.doc
Date of last change:2021/11/24
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase